Rassoul Dinarvand

@tums.ac.ir

Faculty of Pharmacy
Tehran University of Medical Sciences

Rassoul Dinarvand
Rassoul Dinarvand, received his Pharm.D. from University of Tehran in 1988. He then successfully completed his M.Sc. in 1990 and his Ph.D. in 1993 in the field of Controlled Drug Delivery Systems at the University of Manchester, UK. He then joined Faculty of Pharmacy, Tehran University of Medical Sciences in 1994 as a faculty member. He was promoted to full professorship in Pharmaceutics in 2005. He then became the Dean of the Faculty of Pharmacy at Tehran University of Medical Sciences in 2009 for 4 years.
Prof. Dinarvand has been active in the pharmaceutical administration in both industry and government at the highest level: seven years as CEO of several Pharmaceutical companies and twice as Deputy Minister of Health and Head of Iran Food and Drug Administration (8 years). He has also been involved in pharmacoeconomy and national drug policy research. However his main research interest is in the area of polymeric drug delivery systems and has published over 350 international papers

EDUCATION

Pharm. D. from Tehran university 1982-1988
M.Sc. from Manchester University 1989-1990
Ph.D. from Manchester University 1991-1994

RESEARCH INTERESTS

Controlled drug delivery
Polymeric drug delivery
Targeted drug delivery
Microparticles
Nanoparticles
Nanomedicine
Anticancer
491

Scopus Publications

25815

Scholar Citations

81

Scholar h-index

413

Scholar i10-index

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

  • Citrus limon-Derived Extracellular Vesicles Promote Hair Growth
    F Raoufimanesh, SM Atyabi, M Mohamadali, ZA Mirshaby, S Irani, ...
    Applied Biochemistry and Biotechnology, 1-29 , 2026
    2026
  • Redox responsive functionalised mesoporous silica nanoparticle for targeted drug delivery of doxorubicin
    SS Mojtabazadeh, M Samadi, S Perseh, S Saei, R Bafkari, F Atyabi, ...
    Journal of Drug Targeting 34 (3), 484-494 , 2026
    2026
    Citations: 1
  • Oral delivery of liraglutide using CPP/hyaluronic acid-modified mesoporous silica nanoparticles: A virus-inspired strategy for intestinal absorption
    N Shams, M Esfandyari-Manesh, M Sharifzadeh, M Amini, Y Fatahi, ...
    Biomaterials Advances, 214714 , 2026
    2026
  • Ultrasensitive electrochemical biosensor based on MXene quantum dots for prostate cancer biomarker detection
    M Safarpoor, A Asfaram, M Ghaedi, R Dinarvand
    Scientific Reports 15 (1), 42722 , 2025
    2025
    Citations: 9
  • PLGA-integrated micro/nanoparticles for cargo delivery and nanomedicine of lung cancer
    S Kakavandi, I Zare, N Esmaeilnejad, M Sarhadi, A Hheidari, S Shojaei, ...
    International Journal of Pharmaceutics, 126339 , 2025
    2025
    Citations: 5
  • Localized co-delivery of in-situ hydrogel containing ibrutinib-PLGA-PEG-folate nanoparticle and octreotide microsphere to glioblastoma
    B Morshedi, M Esfandyari-Manesh, MH Ghahremani, Y Fatahi, ...
    Drug Delivery and Translational Research, 1-23 , 2025
    2025
    Citations: 2
  • Design and fabrication of pH-responsive charge-switchable PEG-CDM-PAMAM nanoassemblies to improve tumor therapy (vol 681, 125852, 2025)
    E Nekoueifard, F Radmanesh, ES Moghadam, S Maghsoudian, ...
    INTERNATIONAL JOURNAL OF PHARMACEUTICS 683 , 2025
    2025
  • Erratum to “Design and fabrication of pH-responsive charge-switchable PEG-CDM-PAMAM nanoassemblies to improve tumor therapy”[Int. Immunopharmacol. 681 (2025) 125852]
    E Nekoueifard, F Radmanesh, ES Moghadam, S Maghsoudian, P Pooyan, ...
    International Journal of Pharmaceutics 683, 125960 , 2025
    2025
  • Non-invasive detection of choroidal melanoma via tear-derived protein corona on gold nanoparticles: a machine learning approach
    H Rakhshandeh, A Nasiraei, H Riazi-Esfahani, B Masoomian, ...
    Scientific Reports 15 (1), 32829 , 2025
    2025
    Citations: 3
  • Innovative triamcinolone acetonide microsuspension for Non-Invasive ocular management of inflammation
    F Zahir-Jouzdani, S Ashrafi, Z Ghaemmaghamian, B Kharazian, ...
    DARU Journal of Pharmaceutical Sciences 33 (2), 32 , 2025
    2025
  • Biguanidylated chitosan nanofiber scaffold: A green approach to promote osteogenesis in calvarial bone regeneration
    M Saber, A Shaabani, R Sedghi, H Motasadizadeh, N Salimiyan, ...
    Carbohydrate Polymers 364, 123736 , 2025
    2025
    Citations: 9
  • Localized synergistic co-delivery to glioblastoma by in-situ GelMA containing ibrutinib-PLGA-PEG-folate nanoparticle and octreotide microsphere
    B Morshedi, M Esfandyari-Manesh, MH Ghahremani, Y Fatahi, ...
    2025
  • The influence of protein corona on liposomal delivery systems: A comprehensive review
    S Mojarad-Jabali, Y Fatahi, R Dinarvand
    European Journal of Pharmaceutical Sciences 212, 107166 , 2025
    2025
    Citations: 11
  • Design and fabrication of pH-responsive charge-switchable PEG-CDM-PAMAM nanoassemblies to improve tumor therapy
    E Nekoueifard, F Radmanesh, ES Moghadam, S Maghsoudian, P Pooyan, ...
    International Journal of Pharmaceutics 681, 125852 , 2025
    2025
    Citations: 4
  • Effective topical delivery of astaxanthin via optimized chitosan-coated nanostructured lipid carriers: a promising strategy for enhanced wound healing and tissue regeneration
    F Barari, S Maghsoudian, V Alinezhad, SM Ahmadi, FT Amiri, Y Fatahi, ...
    Journal of Drug Delivery Science and Technology 110, 107052 , 2025
    2025
    Citations: 8
  • Co-delivery of SN38 and rapamycin albumin bound nanoparticles against breast Cancer
    S Jamshidfar, M Ebrahimi, R Varshochian, N Goodarzi, J Firouzi, ...
    DARU Journal of Pharmaceutical Sciences 33 (2), 26 , 2025
    2025
  • Synergistic effect of Yes-associated protein siRNA and temozolomide against glioblastoma using a localized nano delivery system
    A Foroohari, B Morshedi, M Heydari, F Khonsari, MHF Nasab, Y Fatahi, ...
    International Journal of Biological Macromolecules, 146234 , 2025
    2025
    Citations: 2
  • Local delivery of ibrutinib by folate receptor-mediated targeting PLGA–PEG nanoparticles to glioblastoma multiform: in vitro and in vivo studies
    B Morshedi, M Esfandyari-Manesh, F Atyabi, MH Ghahremani, ...
    Journal of Drug Targeting 33 (6), 1026-1041 , 2025
    2025
    Citations: 10
  • Synergistic effects of paclitaxel and platelet-superparamagnetic iron oxide nanoparticles for targeted chemo-hyperthermia therapy against breast cancer
    M Tavakoli, S Maghsoudian, A Rezaei-Aderiani, M Hajiramezanali, ...
    Colloids and Surfaces B: Biointerfaces 251, 114584 , 2025
    2025
    Citations: 24
  • Docetaxel-dimer prodrug as a glutathione-responsive nano drug delivery system for improved chemotherapy
    Z Imani, M Amini, MH Ghahremani, F Khonsari, S Shahbaz, F Atyabi, ...
    Journal of Pharmaceutical Sciences, 103874 , 2025
    2025
    Citations: 2

MOST CITED SCHOLAR PUBLICATIONS

  • Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
    R Dinarvand, nima Sepehri, S Manoochehri, H Rouhani, F Atyabi
    International journal of nanomedicine, 877-895 , 2011
    2011
    Citations: 625
  • Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method
    MR Avadi, AMM Sadeghi, N Mohammadpour, S Abedin, F Atyabi, ...
    Nanomedicine: Nanotechnology, Biology and Medicine 6 (1), 58-63 , 2010
    2010
    Citations: 561
  • The significance of artificial intelligence in drug delivery system design
    P Hassanzadeh, F Atyabi, R Dinarvand
    Advanced drug delivery reviews 151, 169-190 , 2019
    2019
    Citations: 379
  • A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis
    SS Abolmaali, AM Tamaddon, R Dinarvand
    Cancer chemotherapy and pharmacology 71 (5), 1115-1130 , 2013
    2013
    Citations: 301
  • Development of dispersive liquid–liquid microextraction combined with gas chromatography–mass spectrometry as a simple, rapid and highly sensitive method for the determination …
    H Farahani, P Norouzi, R Dinarvand, MR Ganjali
    Journal of Chromatography A 1172 (2), 105-112 , 2007
    2007
    Citations: 296
  • Antibody-drug conjugates: possibilities and challenges
    MR Nejadmoghaddam, A Minai-Tehrani, R Ghahremanzadeh, ...
    Avicenna journal of medical biotechnology 11 (1), 3 , 2019
    2019
    Citations: 292
  • Schiff's bases and crown ethers as supramolecular sensing materials in the construction of potentiometric membrane sensors
    F Faridbod, MR Ganjali, R Dinarvand, P Norouzi, S Riahi
    Sensors 8 (3), 1645-1703 , 2008
    2008
    Citations: 283
  • Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method
    TSJ Kashi, S Eskandarion, M Esfandyari-Manesh, SMA Marashi, ...
    International journal of nanomedicine, 221-234 , 2012
    2012
    Citations: 281
  • Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate
    F Esmaeili, MH Ghahremani, SN Ostad, F Atyabi, M Seyedabadi, ...
    Journal of drug targeting 16 (5), 415-423 , 2008
    2008
    Citations: 269
  • Pharmaceutical supply chain risks: a systematic review
    M Jaberidoost, S Nikfar, A Abdollahiasl, R Dinarvand
    DARU Journal of Pharmaceutical Sciences 21 (1), 69 , 2013
    2013
    Citations: 256
  • Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study
    H Hosseinzadeh, F Atyabi, R Dinarvand, SN Ostad
    International journal of nanomedicine, 1851-1863 , 2012
    2012
    Citations: 254
  • Optimization of tetrazolium salt assay for Pseudomonas aeruginosa biofilm using microtiter plate method
    P Sabaeifard, A Abdi-Ali, MR Soudi, R Dinarvand
    Journal of microbiological methods 105, 134-140 , 2014
    2014
    Citations: 242
  • National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic
    N Peykari, H Hashemi, R Dinarvand, M Haji-Aghajani, R Malekzadeh, ...
    Journal of Diabetes & Metabolic Disorders 16 (1), 3 , 2017
    2017
    Citations: 239
  • Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab
    P Yousefpour, F Atyabi, E Vasheghani-Farahani, AAM Movahedi, ...
    International journal of nanomedicine, 1977-1990 , 2011
    2011
    Citations: 234
  • PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution
    F Esmaeili, MH Ghahremani, B Esmaeili, MR Khoshayand, F Atyabi, ...
    International journal of pharmaceutics 349 (1-2), 249-255 , 2008
    2008
    Citations: 215
  • Simultaneous voltammetric determination of tramadol and acetaminophen using carbon nanoparticles modified glassy carbon electrode
    F Ghorbani-Bidkorbeh, S Shahrokhian, A Mohammadi, R Dinarvand
    Electrochimica Acta 55 (8), 2752-2759 , 2010
    2010
    Citations: 209
  • Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods
    M Jaberidoost, L Olfat, A Hosseini, A Kebriaeezadeh, M Abdollahi, ...
    Journal of pharmaceutical policy and practice 8 (1), 9 , 2015
    2015
    Citations: 206
  • Developments in the field of conducting and non-conducting polymer based potentiometric membrane sensors for ions over the past decade
    F Faridbod, MR Ganjali, R Dinarvand, P Norouzi
    Sensors 8 (4), 2331-2412 , 2008
    2008
    Citations: 206
  • Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles
    F Esmaeili, M Hosseini-Nasr, M Rad-Malekshahi, N Samadi, F Atyabi, ...
    Nanomedicine: Nanotechnology, Biology and Medicine 3 (2), 161-167 , 2007
    2007
    Citations: 205
  • Preparation, characterisation, and drug release from thermoresponsive microspheres
    A D'Emanuele, R Dinarvand
    International journal of pharmaceutics 118 (2), 237-242 , 1995
    1995
    Citations: 192